Furthermore, among 150 breast cancer risk regions identified by genome-wide association studies [112], several ERGs identified in this study (BARX2, CBX6, KCNN4, MYEOV, PDZK1 in 300 ERGs) were included as the targets for cancer drivers, transcription factors, and signaling proteins. This evidence concerns the gene MYEOV and breast carcinoma.